Skip to main content
. 2021 May 28;12:676088. doi: 10.3389/fimmu.2021.676088

Figure 4.

Figure 4

Inflammasomes mRNA expression of cells treated with different concentrations of LPS for 24 h. (A) NLRP3, (B) ASC, (C) Caspase-1, (D) Caspase-4, and (E) GSDMD. Each treatment had three samples (n = 3) and was repeated three times to reduce system errors; “※” means there was a significant difference (P < 0.05) compared with negative control (LPS, 0 µg/ml).